C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2004
11/11/2004	US20040224410 DNA virus for use as transfection and protein expression tool in genetic engineering; bioreactors for screening protein folding activities; diagnosis and treatment of polypeptide misfolding disorders
11/11/2004	US20040224409 Replication defective plasmid comprising nucleotide sequences coding nerve growth factor for use in the treatment and/or prevention of degenerative neurological diseases; tissue engineering and targeted therapy
11/11/2004	US20040224404 Conditionally replicating viral vectors and their use
11/11/2004	US20040224308 Nucleotide sequences coding viral glycoprotein for use in generating modulators for prevention and treatment of viral infection; viricides; immunotherapy
11/11/2004	US20040224305 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
11/11/2004	US20040223980 Cold-adapted equine influenza viruses
11/11/2004	US20040223979 Chimeric flavivirus vaccines
11/11/2004	US20040223974 Vaccines, immunotherapeutics and methods for using the same
11/11/2004	US20040223954 isolated phage from the Myoviridae family having a genome size of 170 kb and lytic activity against pathogenic E. coli or Salmonella strainsin used in particular for phage therapy of pediatric gastroenteritis or Salmonella infection
11/11/2004	CA2523875A1 Sars virus nucleotide and amino acid sequences and uses thereof
11/11/2004	CA2523319A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
11/10/2004	EP1474521A2 An herpes simplex virus complex
11/10/2004	EP1474519A2 Microorganism for genetic therapeutic treatment of proliferative diseases
11/10/2004	CN1545550A Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same
11/10/2004	CN1544625A Method for construction of bombyx mori virus fast gene expression system utilizing bacterium transposon
11/09/2004	US6815200 Modified adenovirus containing a fiber replacement protein
11/09/2004	US6815159 Generation of viral protease; obtain polypeptide, incubate with chaotropic agent, fold, recover protease
11/09/2004	US6814969 Epitopes recognized by t-cells (cd-8/cd-4 antigens) derived from herpetic lesions; fusion proteins; antigen presenting cells; vaccines
11/09/2004	US6814963 Baculovirus-based expression system
11/04/2004	WO2004094476A2 Compositions and methods relating to stop-1
11/04/2004	WO2004094466A2 Recombinant influenza viruses holding a mutation in a transmembrane protein gene
11/04/2004	WO2004062584A3 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
11/04/2004	WO2002086070A3 Binding molecules for fc-region polypeptides
11/04/2004	US20040220123 therapy for bactericide infections which are drug resistance, antibiotic resistance; anticancer agents; hybrid nucleic acids;
11/04/2004	US20040220076 Prevention of recurrent viral disease
11/04/2004	US20040219674 Virus envelope vector for gene transfer
11/04/2004	US20040219655 Nanoscale particles synthesized within an assembled virion
11/04/2004	US20040219642 Using expression vector comprising nucleotide sequences coding interferon-specific transcriptional regulators and interferon receptors to transform cells and intensify expression of interferon; antiviral agents; antitumor agents
11/04/2004	US20040219516 Expression vector comprising multiple recombination and/or topoisomerase sites for use as gene transfer tool in ptokaryotic and eukaryotic cells
11/04/2004	US20040219171 In ovo protection against infectious bronchitis
11/04/2004	US20040219170 Viruses encoding mutant membrane protein
11/04/2004	US20040219166 EIA vaccine and diagnostic
11/04/2004	US20040219164 Advanced antigen presentation platform
11/04/2004	CA2526914A1 Compositions and methods relating to stop-1
11/04/2004	CA2522081A1 Recombinant influenza viruses holding a mutation in a transmembrane protein gene
11/03/2004	EP1473361A2 Genetically engineered attenuated viruses
11/03/2004	EP1471937A1 A continuous cell line for the production of vaccines
11/03/2004	EP1471873A2 Flavivirus vaccines
11/03/2004	CN1542132A Highly expressed recombinant virus containing human constant region all-antibody gene and its use for treating tumor
11/03/2004	CN1541714A Gene transfer-mediated angiogenesis therapy
11/02/2004	US6811972 For preparing a hybridoma cell line which specifically recognizes and binds tumor associated antigen; antibodies; prostate carcinoma tumor antigen gene-1
11/02/2004	US6811784 Recombinant parainfluenza virus expression system and vaccines
11/02/2004	US6811775 Reovirus for the treatment of cellular proliferative disorders
11/02/2004	US6811774 Defective recombinant adenoviruses expressing cytokines for antitumor treatment
10/2004
10/28/2004	WO2004092387A1 Viral vectors expressing fusion of viral large envelope protein and protein of interest
10/28/2004	WO2004092360A2 The severe acute respiratory syndrome coronavirus
10/28/2004	WO2004092348A2 Method for production of oncolytic adenoviruses
10/28/2004	WO2004091505A2 Bacteriophage for lysis of methylobacterium and compositions and uses thereof
10/28/2004	US20040214331 Transforming and propagating viral-like particle in cells; for use as tools in prevention and treatment of viral infection; viricides and genetic vaccines
10/28/2004	US20040214277 Methods and compositions for polypeptide engineering
10/28/2004	US20040214160 Using viruses to detect or purify proteins
10/28/2004	US20040213799 Boosting priming composition with nonreplicating and/or replication impaired strains of poxvirus vectors; forming human immunodeficiency virus inhibitors
10/28/2004	CA2523693A1 Bacteriophage for lysis of methylobacterium and compositions and uses thereof
10/27/2004	EP1471147A2 Method of making a recombinant molecule for the expression of HPV-16 L1 protein
10/27/2004	EP1471146A2 A packaging cell line expressing for use in facilitating the development of high capacity adenoviral vectors
10/27/2004	EP1471142A1 Heterodimeric receptor libraries using phagemids
10/27/2004	EP1470218A2 Corona-virus-like particles comprising functionally deleted genomes
10/27/2004	EP1469730A2 Methods and compositions for treating parkinson's disease
10/27/2004	EP1250050B1 Method and device for sanitation using bacteriophages
10/27/2004	EP0717108B1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins
10/27/2004	CN1541265A Identification of DNA variant associated with adult type hypolactasia
10/27/2004	CN1541226A Antibodes specific for CD44V6
10/27/2004	CN1541101A Methods of polyvalent bacteriophage prepn. for treatment of bacterial infections
10/27/2004	CN1539965A Recombined baculovirus of insect, preparation method and application as insecticide
10/27/2004	CN1173039C Variant loxP sequences and application of the same
10/27/2004	CN1173032C Recombinant herpesvirus carrying antivasculr and antiendothelial cell factors fusion gene
10/26/2004	US6808922 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
10/26/2004	US6808916 Method of extracting virus from cell culture
10/21/2004	WO2004089983A2 Severe acute respiratory syndrome (sars) causing coronavirus
10/21/2004	WO2004078912A3 Chicken rna polymerase i promoter and the use thereof
10/21/2004	WO2004062567A3 Arterivirus marker vaccine
10/21/2004	WO2004042025A3 Cell-specific adenovirus vector comprising ebv-specific promoter
10/21/2004	WO2004040973A3 Organellar targeting of rna and its use in the interruption of environmental gene flow
10/21/2004	WO2004009032A3 Method and composition for treating and preventing hepatitis b infection and symptoms thereof
10/21/2004	US20040209364 Enhancced adeno-associated viral vector for use as gene transfer tool in genetic engineering and gene therapy; antitumor agents
10/21/2004	US20040208900 mutant rabies virus comprising a rabies virus N protein that is not phosphorylated; central nervous system (CNS)
10/21/2004	US20040208899 Apparatus for diagnosis and treatment of swine infertility and respiratory virus (SIRS) syndrome; vaccines
10/21/2004	US20040208895 administering HETEROLOGOUS GENE PRODUCTS IN HOST CELL SYSTEMS AND/OR TO RESCUE NEGATIVE STRAND RNA RECOMBINANT VIRUSES
10/21/2004	US20040208850 Antitumor agents; enhanced by administration of cytoxic T lymphocyte (CTLA-4) blocker and/or cytosine-guanosine (CpG) oligodeoxynucleotide immunomodulators
10/21/2004	US20040208849 Reducing viability of tumor cell by administering virus that is not a common human pathogen such as a Rhabdovirus, a picomavirus, and preferably is vesicular stomatitis virus (VSV)
10/21/2004	US20040208848 Contains multiplicity of expressible coding sequences derived from the neoplastic cell, pathogen or parasite, and gene expression of coding sequences in a human or animal; immunogens for vaccines; antitumor and anticarcinogenic agents; viral replicon selected nucleic acid expression libraries
10/21/2004	DE10317008A1 New recombinant equine herpes (EHV) virus free of heterologous elements, and where protein gM has been deleted, useful as a vaccine for treating or preventing EHV infections
10/21/2004	CA2521856A1 Severe acute respiratory syndrome (sars) causing coronavirus
10/20/2004	EP1469077A1 Cell-specific expression/replication vector
10/20/2004	EP1469076A2 Recombinant PRRS proteins, diagnostic kits and vaccines containing said recombinant proteins
10/20/2004	EP1468100A2 Gb virus b based replicons and replicon enhanced cells
10/20/2004	EP1468080A1 INFECTIOUS cDNA CLONES OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EXPRESSION VECTORS THEREOF
10/20/2004	EP1468078A1 Method and device for identifying substances capable of modulating adipocyte differentiation
10/20/2004	EP1467754A1 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus
10/20/2004	EP1467753A2 Recombinant herpesvirus of turkeys and use thereof
10/20/2004	EP1194450B1 Inactivated vaccine against feline calicivirus disease
10/20/2004	EP0956355B1 Method for immortalizing cells
10/20/2004	CN1171996C American pig reproduction and respiratory syndrome syndrome (PRRS) virus and its use
10/20/2004	CN1171852C Method for inactivating virus in bio-composition
10/20/2004	CN1171636C Hepatitis B DNA vaccine
10/19/2004	US6806086 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
10/19/2004	US6805870 Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament
10/19/2004	US6805867 Bovine rotavirus genes
10/19/2004	CA2059898C Biologically active bacillus thuringiensis isolates and gene encoding a coleopteran-active toxin
10/14/2004	WO2004087900A1 Complete empty viral particles of infectious bursal disease virus (ibdv), production method thereof and applications of same

1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 267